Skip to content
Search

Latest Stories

Increase protected learning time for NHS pharmacists – GHP launches national campaign

GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”


The organisation highlighted the existing inconsistency across the UK regarding the amount of SPA time allocated to pharmacists and stressed the need for a consistent amount of development to “allow pharmacists to be able to be safe practitioners, to meet the demands of service development, and to be able to safely mentor and supervise more junior colleagues.”

The GHP raised concerns that many pharmacists end up doing “unpaid work” to catch up with the required training or completing self-learning in their own time.

“This pressure is unfair and unsustainable, potentially contributing to burnout and in combination with all the other pressures, leads to pharmacists leaving the NHS,” it stated.

The GHP asserted that a minimum of 10% of contracted hours for SPA is “a strongly justifiable argument.”

“This is to reflect the increase in professional responsibilities such as supervising junior colleagues with their prescribing, supporting undergraduate students, postgraduate education requirements, portfolio development, professional credentialing, and much more,” it explained.

The organisation stressed that it is within the scope of trusts, health boards and employers to grant this time to pharmacists, citing similar provisions in other professions.

Rob Connah, president of the GHP, underscored the urgency of implementing mandated protected learning time (PLT), particularly with the introduction of the General Pharmaceutical Council’s ‘Standards for the Initial Education and Training of Pharmacists’ in 2021.

With the new standards, all newly registered pharmacists would be able to prescribe independently from 2026.

Connah told The Pharmaceutical Journal: “There is a drastic increase of experiential learning, which places an emphasis on practice supervisors, and from 2025–2026, this will increase again to include a responsibility for developing safe prescribers at the point of registration.

“This increase in responsibility is a national expectation with little additional resource seen for individual pharmacists to accommodate.

“As services develop and become increasingly reliant upon specialist pharmacist skills and knowledge, the need for postgraduate qualifications has similarly increased. Services are limited by poor recruitment, retention and staff burnout.”

Claire Anderson, president of the Royal Pharmaceutical Society (RPS), echoed these concerns, calling on governments, NHS bodies, and employers to ensure regular, funded PLT and the infrastructure needed to support it to enable continuous professional development from foundation pharmacists to consultant level across Great Britain.

“We believe it is essential that learning time is considered in any future workforce plans,” she said.

Anderson also noted that PLT was a key topic at their 2024 workforce wellbeing roundtable with Pharmacist Support and will remain central to discussions with stakeholders on collaborative efforts to better support the pharmacy workforce.

A survey conducted by the Pharmacists’ Defence Association (PDA) in January revealed that over two-thirds of frontline pharmacists had not received protected learning time during contracted hours or financial compensation from their employer for training related to Pharmacy First.

Regarding future service expansions, 97% of respondents agreed that protected learning time or paid training should be mandatory to support pharmacists and staff in delivering additional pathways and conditions.

Additionally, three-quarters (75%) of surveyed pharmacists felt that the pharmacies they work in were not adequately staffed to safely deliver Pharmacy First and other NHS contractual services.

Locum pharmacists expressed challenges in completing extensive training without compensation for their time or lost earnings, while part-time pharmacists reported feeling stressed due to time pressures associated with training.

More For You

Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less